logo

Sector: Pharmaceuticals & Biotechnology

|

Mid Cap

Alivus Life Sciences Share Price

Alivus Life Sciences Ltd.

1,007

22.80(2.32%)

Invest in ALIVUS with up to 2.50x margin.

Trade with MTF
2nd Apr 2026 | 3:28 PM
NSE : ALIVUS
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Alivus Life Sciences Performance

Price Movement

₹1007.00

₹957.00

₹1010.00

Today's LowToday's High

1 Year Performance

₹1007.00

₹819.00

₹1225.10

52 Week Low52 Week High

Markets Today

High₹1,010.00
Low₹957.00
Open at₹980.00
Prev Close₹984.20
Volumes38.76 K
Avg Price₹978.47
Lower Circuit₹787.40
Upper Circuit₹1,181.00

Historical Performance

3M High₹1,025.00
3M Low₹819.00
1 Yr High₹1,225.10
1 Yr Low₹819.00
3 Yr High₹1,335.10
3 Yr Low₹390.20
5 Yr High₹1,335.10
5 Yr Low₹370.00

Alivus Life Sciences Fundamentals

Market Cap
High in industry
12,146 Cr.
PE Ratio (TTM)
Above industry Median
22.30
Dividend Yield
Below industry Median
0.50
Net Profit TTM
23.1% incr over last year
543.69
Net Profit Growth
23.1% incr over last year
543.69
PEG Ratio
Above industry Median
1
ROE
15% decr over last year
17.23
Operating Revenue TTM
2,512.26
Operating Revenue Growth
10.5% incr over last year
Book Value
Above industry Median
3.80
MFI
MFI is mid-range
65.30
RSI
RSI is mid-range
62.90
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
3.80

Alivus Life Sciences Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue672.89587.98601.85649.54641.84
Operating Expense441.62408.81429.54451.11451.54
Operating Profit231.27179.17172.31198.43190.31
Depreciation19.6618.4417.0615.9715.16
Interest1.491.321.251.260.46
Tax48.1344.1141.4549.4248.19
Net Profit150.26130.03121.54141.87136.96

ALIVUS Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

882 - ₹899

Target Price

1,077

Stop Loss

-

Target Date

26 Jan 27

Potential Returns

22.11 %

View Call ↗

Alivus Life Sciences Technicals

Alivus Life Sciences Ltd. EMA & SMA

1007.00

22.80 (2.32%)

Bullish Moving Average

16

Bearish Moving Average

0

Day EMA5 ₹974.1
Day EMA10 ₹962.8
Day EMA12 ₹959.2
Day EMA20 ₹948.5
Day EMA26 ₹942.9
Day EMA50 ₹930.5
Day EMA100 ₹927.2
Day EMA200 ₹942.3

Alivus Life Sciences Support and Resistance

Resistance

First Resistance₹1007.35
Second Resistance₹1030.50
Third Resistance₹1047.65

Support

First Support₹967.05
Second Support₹949.90
Third Support₹926.75

Technical Indicators

Day RSI62.90
Day MFI65.30
Day ADX21.04
Day Commodity Channel Index151.10
William-34.98
Day MACD16.30
Day MACD Signal Line11.64
Day ATR34.71
Day ROC1254.79
Day ROC216.97

Alivus Life Sciences Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter75757574.974.974.9
FII7.86.76.66.46.85.1
DII4.24.95.25.65.57.1
Public1313.413.21312.812.9

Alivus Life Sciences Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day45.71 K93 K49.15%
Week42.88 K1.06 L40.42%
1 Month40.76 K78.67 K51.81%
6 Month67.44 K1.09 L62.12%

Alivus Life Sciences SWOT Analysis

Strengths19
Weakness5
Opportunity5
Threats3

Companies with no Debt

Benjamin Graham Value Screen

Strong Momentum: Price above short, medium and long term moving averages

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing profits every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Alivus Life Sciences Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
01 Sep, 20255FINAL01 Sep, 2025Equity Share
17 Oct, 202322.5INTERIM17 Oct, 2023Equity Share
24 Mar, 202321INTERIM24 Mar, 2023Equity Share
15 Sep, 202210.5FINALEquity Share
22 Nov, 202110.5INTERIM23 Nov, 2021Equity Share

Alivus Life Sciences Stock Comparison

Financials
Price (₹)₹1,500₹615₹775₹1,395₹4,578₹496.65
% Change-2.66%0.16%-0.91%-2.88%0.93%0.04%
Revenue TTM (₹ Cr)--₹1,598.19₹1,419.33₹878.40₹4,256.70
Net Profit TTM (₹ Cr)--₹206.20₹20.10₹240.10₹318.19
PE TTM--62.00800.8043.9024.70
1 Year Return41.173.7359.76-13.79-4.85.55
ROCE30.2434.7834.763.26-11.27

FAQ's on ALIVUS

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy